Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.
about
Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigmClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationAssociation of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients.Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patientsAn optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women.Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical TransmissionImmune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?The "ABC" of Virus-Specific T Cell Immunity in Solid Organ Transplantation.Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant.Testing for Cytomegalovirus in Pregnancy.Cytomegalovirus infection in lung transplant recipients.Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation.Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients.Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.Immune monitoring of infectious complications in transplant patients: An important step towards improved clinical management.Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study.
P2860
Q26850340-208B4D1F-B0CC-472A-BA6C-599314673BA4Q26998832-9F23B5B6-FE36-40CD-B2B8-4820C71C162CQ35760200-43359C96-061E-4FFA-B1B0-12DB3C1F460CQ35818931-D0130E5A-79BA-40F3-9D09-55DC0092AF18Q36299933-4C9E0038-C9CD-4184-A05E-7C3A76A10228Q36300011-D281818D-BD1D-454A-818F-6554F511275AQ36834814-956F897F-404E-49C9-80F5-3B3BDE4B34D4Q37132000-788026F5-23FC-4AAD-8FBD-3DFAB9E38234Q37504023-D5461903-83BF-4AF7-9AD8-7D245472385DQ38235723-43504F27-3885-49CB-B7B6-FFDD2E48C40AQ38677902-84141135-85FB-4755-90C8-5FF89CA5DDFDQ39037833-C82CC209-B079-45E4-8328-1C9ECC1007AAQ39061544-1228C6FF-D718-4D70-8BFC-09B9A70B5791Q39226830-CE4E09C4-7A8B-48F9-A84A-1F4D0CD7D75DQ40163004-B3DED442-C3FE-41C4-938F-ECD78981B138Q41099122-B0FD0E7A-A181-4086-ABFF-6198C0F51EB3Q42246073-CBD5D4A3-546B-4FD7-98F6-A072ECB91B1DQ47101572-BCCB1BAD-6A08-4149-8DEB-D7B0AEC6A02FQ47249337-B1FF21A8-69EB-4250-A7D9-6EC071D1BB68Q47552304-2B256854-C9B3-4DFB-88EC-4B2D0458E3AFQ52585132-3A71A9A1-5EE4-452A-8713-827B49750FA9Q54945543-87116869-3F44-4793-9C41-AF7666E4ED93
P2860
Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of cytomegalovirus ...... kidney transplant recipients.
@en
Comparison of cytomegalovirus
@nl
type
label
Comparison of cytomegalovirus ...... kidney transplant recipients.
@en
Comparison of cytomegalovirus
@nl
prefLabel
Comparison of cytomegalovirus ...... kidney transplant recipients.
@en
Comparison of cytomegalovirus
@nl
P2093
P2860
P50
P356
P1476
Comparison of cytomegalovirus ...... kidney transplant recipients.
@en
P2093
Barbara Rossi
Davide Abate
Francesco Marchini
Loredana Fallico
Luciana Bonfante
Lucrezia Furian
Marta Fiscon
Marta Peracchi
Riccardo Cusinato
P2860
P304
P356
10.1128/JCM.00563-13
P407
P577
2013-05-15T00:00:00Z